Latest filing published 17 May 2024 for Aerovate Therapeutics, Inc., €20k. Read the official filing
Timothy P. Noyes is a declared insider at 2 companies; the most frequent names are Jade Biosciences, Inc. and Protara Therapeutics, Inc. In total, 18 filings cover trades dated from 4 January 2016 to 16 May 2024.
Every open-market trade on record is a sale: 4 sales worth €121k. The totals exclude 1 filing filed without an amount. The rest of the record consists of 14 option exercises.
The record was last updated on 17 May 2024 with an option exercise (€20k) in Jade Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations